Company intelligence / Profile preview

Beacon CMP

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Beacon is a premier clinical trial and drug development intelligence platform specifically designed for the life sciences industry. Operated by Hanson Wade, the platform provides deep, curated data on complex therapeutic modalities including antibody-drug conjugates (ADCs), cell and gene therapies, and RNA therapeutics. It serves as a critical resource for biotech analysts and pharmaceutical companies by tracking clinical trial progress, drug pipelines, and competitive landscapes in real-time. The platform is modular, with specific databases dedicated to high-growth areas of drug discovery and development.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Beacon CMP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beacon CMP.

Explore the full profile